Increased serum and cerebrospinal fluid levels of the acute phase protein SERPINA3 are associated with Alzheimer disease [88]; however, it is also thought to limit inflammation by controlling superoxide generation and inhibiting proteases, such as elastase and chymase, with cathepsin G thought to be its primary target [89]. This evidence concerns the gene CTSG and Alzheimer disease.